Finally, it would also be of interest to determine if combining ROCK1 deficiency with antioxidants only provides synergistic protective effects to normal cells, without reducing the tumor cell-killing ability of anti-tumor drugs including doxorubicin. The gene discussed is ROCK1; the disease is neoplasm.